• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成熟肝细胞的单细胞分析揭示了由干扰素调节因子1驱动的丁型肝炎病毒感染限制。

Single-cell analysis of mature hepatocytes reveals an IRF1-driven restriction of HDV infection.

作者信息

Lange Frauke, Garn Jonathan, Bruhn Matthias, Pietschmann Thomas, Carpentier Arnaud

机构信息

Institute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between Hannover Medical School (MHH) and Helmholtz Centre for Infection Research (HZI), Hannover, Germany.

Institute for Experimental Infection Research, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between Hannover Medical School (MHH) and Helmholtz Centre for Infection Research (HZI), Hannover, Germany.

出版信息

JHEP Rep. 2025 Apr 22;7(8):101429. doi: 10.1016/j.jhepr.2025.101429. eCollection 2025 Aug.

DOI:10.1016/j.jhepr.2025.101429
PMID:40677689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12269598/
Abstract

BACKGROUND & AIMS: Stem cell-derived hepatocyte-like cells (HLCs) are an model of hepatocytes reproducing mature hepatic functions. However, heterogeneous or imperfect differentiation may limit their biological relevance. HLCs are susceptible to all primary hepatitis viruses, including HDV. Importantly, HLCs support limited HDV replication, at a significantly lower level than hepatoma cell lines.

METHODS

We used single-cell RNA sequencing (scRNAseq) to analyse control and HDV-infected HLCs. We assessed maturation and heterogeneity of the HLCs population. We visualised viral genomic and antigenomic sequences abundance and innate immune response at the single-cell level. Further functional characterisation was performed in HLCs and hepatoma cell lines.

RESULTS

HLCs form a population of hepatocytes exhibiting various levels of maturation, with a minor hybrid population of myofibroblast/hepatocyte cells associated with immature phenotype. Upon HDV inoculation, Interferon-Stimulated Genes expression was induced in infected cells, but not in bystander HLCs. Moreover, Interferon Regulatory Factor 1 (IRF1) was enriched in infected HLCs with undetectable levels of viral genome replication, suggesting it may restrict viral infection. Decreasing IRF1 expression in HLCs by 50% improved susceptibility to HDV infection by 10-fold ( <0.01). Moreover, IRF1 overexpression in hepatoma cell lines restored physiological basal level of IRF1 effector antiviral genes and inhibited HDV infection (∼50% reduction after 7 days, <0.01). Importantly, in IRF1 expressing cells, cell division-mediated spread was inhibited and infection was significantly decreased after 2 weeks of culture (>1.5 log decrease, <0.001).

CONCLUSIONS

scRNAseq of HLCs identified IRF1 as a potent restriction factor of HDV infection, through an antiviral mechanism blocking HDV infection at an early step of the viral cycle.

IMPACT AND IMPLICATIONS

We performed single-cell RNA sequencing of control and HDV-inoculated stem cell-derived hepatocytes, and characterised them in terms of hepatic differentiation, viral abundance and response to infection. We identified IRF1 as a constitutive cellular factor restricting HDV infection in mature hepatocytes, particularly targeting HDV in the cytoplasm. This work improves our understanding of mature cell culture models for HDV, needed to decipher its host-pathogens interactions. Identification of antiviral effector genes opens the way to the development of new host targeted antiviral strategies, particularly for targeting cell division-mediated spread that is not inhibited by currently used entry inhibitors (Hepcludex).

摘要

背景与目的

干细胞来源的肝样细胞(HLCs)是再现成熟肝功能的肝细胞模型。然而,异质性或不完全分化可能会限制其生物学相关性。HLCs对所有原发性肝炎病毒均易感,包括丁型肝炎病毒(HDV)。重要的是,HLCs支持有限的HDV复制,其水平显著低于肝癌细胞系。

方法

我们使用单细胞RNA测序(scRNAseq)分析对照和HDV感染的HLCs。我们评估了HLCs群体的成熟度和异质性。我们在单细胞水平上可视化了病毒基因组和反基因组序列的丰度以及先天免疫反应。在HLCs和肝癌细胞系中进行了进一步的功能表征。

结果

HLCs形成了一群表现出不同成熟水平的肝细胞群体,还有一小部分与未成熟表型相关的肌成纤维细胞/肝细胞杂交群体。接种HDV后,感染细胞中诱导了干扰素刺激基因表达,但旁观者HLCs中未诱导。此外,干扰素调节因子1(IRF1)在病毒基因组复制水平不可检测的感染HLCs中富集,表明它可能限制病毒感染。将HLCs中IRF1的表达降低50%可使对HDV感染的易感性提高10倍(P<0.01)。此外,在肝癌细胞系中过表达IRF1可恢复IRF1效应抗病毒基因的生理基础水平并抑制HDV感染(7天后降低约50%,P<0.01)。重要的是,在表达IRF1的细胞中,细胞分裂介导的传播受到抑制,培养2周后感染显著减少(>1.5个对数级下降,P<0.001)。

结论

HLCs的scRNAseq确定IRF1是HDV感染的有效限制因子,通过一种抗病毒机制在病毒周期的早期阶段阻断HDV感染。

影响与意义

我们对对照和接种HDV的干细胞来源的肝细胞进行了单细胞RNA测序,并在肝分化、病毒丰度和感染反应方面对其进行了表征。我们确定IRF1是一种在成熟肝细胞中限制HDV感染的组成性细胞因子,特别是在细胞质中靶向HDV。这项工作增进了我们对HDV成熟细胞培养模型的理解,这对于解读其宿主-病原体相互作用是必要的。抗病毒效应基因的鉴定为开发新的宿主靶向抗病毒策略开辟了道路,特别是针对目前使用的进入抑制剂(Hepcludex)未抑制的细胞分裂介导的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/70d51ed3d99e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/0d2e04af3bc5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/5950d6b182c2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/86371791eb91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/bd53fcaea41b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/67636daa62e0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/2f88ad5df324/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/768b0b21e73a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/d9ae2c25f5d6/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/70d51ed3d99e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/0d2e04af3bc5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/5950d6b182c2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/86371791eb91/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/bd53fcaea41b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/67636daa62e0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/2f88ad5df324/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/768b0b21e73a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/d9ae2c25f5d6/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c8c/12269598/70d51ed3d99e/gr8.jpg

相似文献

1
Single-cell analysis of mature hepatocytes reveals an IRF1-driven restriction of HDV infection.成熟肝细胞的单细胞分析揭示了由干扰素调节因子1驱动的丁型肝炎病毒感染限制。
JHEP Rep. 2025 Apr 22;7(8):101429. doi: 10.1016/j.jhepr.2025.101429. eCollection 2025 Aug.
2
Reconstitution of interferon regulatory factor 7 expression restores interferon beta induction in Huh7 cells.干扰素调节因子7表达的重建可恢复Huh7细胞中β干扰素的诱导。
J Virol. 2025 Jun 17;99(6):e0070325. doi: 10.1128/jvi.00703-25. Epub 2025 May 23.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.急性丙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD011644. doi: 10.1002/14651858.CD011644.pub2.
8
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.

本文引用的文献

1
An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes.人多能干细胞来源的肝细胞用于乙型和丁型肝炎病毒感染模型的建立。
EMBO Rep. 2024 Oct;25(10):4311-4336. doi: 10.1038/s44319-024-00236-0. Epub 2024 Sep 4.
2
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.布乐瑞肽联合聚乙二醇干扰素治疗慢性丁型肝炎。
N Engl J Med. 2024 Jul 11;391(2):133-143. doi: 10.1056/NEJMoa2314134. Epub 2024 Jun 6.
3
Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.
肝细胞固有先天抗病毒免疫对乙型肝炎 Delta 病毒感染的作用:来自真正人类肝细胞的声音。
Viruses. 2024 May 8;16(5):740. doi: 10.3390/v16050740.
4
Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies.乙型和丁型肝炎病毒感染的细胞培养模型:旧挑战、新进展与未来策略。
Viruses. 2024 Apr 30;16(5):716. doi: 10.3390/v16050716.
5
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.蓝病毒单药治疗慢性 HDV 患者:一项 III 期随机试验中至第 96 周的疗效和安全性结果。
J Hepatol. 2024 Oct;81(4):621-629. doi: 10.1016/j.jhep.2024.05.001. Epub 2024 May 9.
6
Use of stem cell-derived hepatocytes to model liver disease.利用干细胞衍生的肝细胞建立肝脏疾病模型。
J Hepatol. 2024 May;80(5):826-828. doi: 10.1016/j.jhep.2023.11.029. Epub 2024 Feb 15.
7
Hepatitis D: A Review.肝炎 D:综述。
JAMA. 2023 Dec 26;330(24):2376-2387. doi: 10.1001/jama.2023.23242.
8
Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications.多能干细胞诱导的肝细胞样细胞:诱导方法与应用。
Int J Mol Sci. 2023 Jul 18;24(14):11592. doi: 10.3390/ijms241411592.
9
Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes.肝干细胞源性肝细胞中的乙型肝炎 D 病毒感染、先天免疫反应和抗病毒治疗。
Liver Int. 2023 Oct;43(10):2116-2129. doi: 10.1111/liv.15655. Epub 2023 Jun 27.
10
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.慢性丁型肝炎的布乐瑞肽 3 期随机临床试验。
N Engl J Med. 2023 Jul 6;389(1):22-32. doi: 10.1056/NEJMoa2213429. Epub 2023 Jun 22.